LONDON (Reuters) - Britain's cost watchdog has recommended that patients with high cholesterol should not get Sanofi and Regeneron's new cholesterol-lowering injection Praluent, although Amgen's similar drug Repatha will be available.
http://ift.tt/xePdMM
from Reuters: Health News
via
animenewspro
Aucun commentaire:
Enregistrer un commentaire